CALGARY -- The death of 15-year-old Mia Wilkinson has rocked her family and friends, the teen girl passed away suddenly on August 12.

“It really hits home and it's gut wrenching,” said Kendra Myhre, a long-time friend of the family.

“I am so upset and hurt and devastated.”

 

Mia was diagnosed with Ohtahara syndrome when she was a baby, which causes her to have severe seizures and sometimes she could have up to 100 episodes every day. When Mia was about seven years old, her mom Sarah explored cannabis oil and it changed Mia’s life.

Since then, Sarah has worked to educate and counsel other families about the benefits of cannabis for children who suffer from severe seizures.

e-mail icon

Some dads turn to cannabis to get the boost they need to play with their children when they can’t naturally turn it on.

When it comes to parenting, certain dads believe that, when consumed responsibly, cannabis makes them a better parent.

To date, little research has explored the topic at length. However, as is the case with most cannabis claims, scores of anecdotal findings fill the research void for many fathers.

In addition to self-reports, studies focusing on the effects of marijuana allow for dads to deduce for themselves if such experiences may improve their parenting. These are some of the most common benefits consumers claim.

Photo by Nikada/Getty Images

Mood Enhancement

Playtime is an essential, can’t-miss way for dads to bond with their kids.

How To Talk To Your Kids About Cannabis

London, UK, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets, announces its LinkResPet and DailyLifeCBD products will be available for purchase in all four retail locations of Collins Tobacco & Vape Stores. This comes as the Company looks to expand its presence across the marketplace and increase consumer awareness of its pet and human wellness products.

Rene Lauritsen, Link Reservations Inc CEO, commented: “We are very excited to have our products in all four Collins Tobacco & Vape retail locations. In the next few months we hope to continue this growth and have a stronger presence in retail locations across the U.S. and eventually in the Europe and the UK. This is a great way to increase product awareness amongst consumers who are already interested in CBD products but haven’t come across our products before. Retail presence for us is clearly a key driver of sales as we look to grow our market share. I look forward to updating investors on any further developments”.

LinkResPet’s products consist of CBD tinctures for dogs and cats. While DailyLifeCBD has a functional mushroom and CBD range of products including its DailyLifeCBD Immune tincture, as well as other CBD products in the pipeline. All products are made with the highest quality hemp oil and are lab tested, THC and GMO free. The hemp oil used in LRSV products comes from organically grown certified U.S. and European hemp. The Company ensures that its products undergo a rigorous process of quality control and testing using the latest scientific methods.

Collins Tobacco & Vape has been in business 12 years and has four locations in Miami & Miami Beach. These are 6750 Collins Ave Miami Beach, 2611 Collins Ave Miami Beach, 1711 N. Bayshore Dr Miami (Grand Hotel) and 2504 NE 2nd Ave Miami.

For more information about LinkResPet or to purchase CBD products for pets, please visit www.linkrespet.com or follow us on Twitter @res_pet

e-mail icon

Epileptic seizures trigger the rapid synthesis and release of a substance mimicked by marijuana’s most psychoactive component, investigators have learned. This substance is called 2-arachidonoylglycerol, or 2-AG, and has the beneficial effect of damping down seizure intensity.

But there’s a downside. The similarly rapid breakdown of 2-AG after its release, the researchers found, trips off a cascade of biochemical reactions culminating in blood-vessel constriction in the brain and, in turn, the disorientation and amnesia that typically follow an epileptic seizure.

The researchers’ discoveries could guide the development of drugs that both curb seizures’ strength and reduce their aftereffects. The findings appear in the journal Neuron.

A ‘STORM’ IN THE BRAIN

About one in every hundred people has epilepsy. Epileptic seizures can be described as an electrical storm in the brain. These storms typically begin at a single spot where nerve cells begin repeatedly firing together in synchrony. The hyperactivity often spreads from that one spot to other areas throughout the brain, causing symptoms such as loss of consciousness and convulsions. It’s typical for the person experiencing a seizure to need tens of minutes before becoming clearheaded again.

The majority of epileptic seizures originate in the hippocampus, a brain structure buried in the temporal lobe, says Ivan Soltesz, co-senior author of the study and professor of neurosurgery at Stanford University School of Medicine.

e-mail icon

CBD-infused items abound at dispensaries and e-commerce sites, ranging from conventional forms like a flower, tinctures, salves, and wax to more fashionable options like pet treats, infused water, coffee, and ice cream.

Cannabidiol oil appears to be touted as a wonder cure-all by everyone. While it won’t give you superpowers, it’s quickly becoming a popular option for people who wish to get the benefits of cannabis’ therapeutic qualities without affecting their mental state.

 

Benefits of CBD that makes it Remain in the Limelight every time

While CBD oil has been the talk of the town for the past year or so, the hype alone isn’t enough to convince you to try a new treatment.

When utilizing cannabidiol for illnesses ranging from everyday discomfort to chronic disorders, patients and researchers have reported some promising results.

Diabetes

Cannabidiol appears to have the potential to reduce diabetes risk and management. Cannabidiol has been shown in studies to decrease insulin levels and enhance pancreatic function, among other things. Because people with diabetes should avoid cannabis foods owing to their high sugar content, diabetes management is an excellent reason to include excellent CBD gummies online or tinctures in their cannabis regimen.

e-mail icon

The latest research report on Medical Cannabis market takes the reader through every crucial aspect that impacts the trajectory and the current industry data and upcoming trends of the industry. The universal Medical Cannabis market analysis report gives us an in-depth overview of the research trends for the financial year 2021. This report studies the Medical Cannabis industry on various parameters such as the raw materials, cost, and technology and consumer preference. It also provides with important market credentials such as the history, various expansions and trends, trade overview, regional markets, trade and also market competitors. Under the analysis on market share by key players, Medical Cannabis report covers capital, revenue, and price analysis by the business along with other sections such as expansion plans, areas assisted, products offered by key manufacturers, alliance and acquisition and headquarters delivery. This report will prove out to be handy for those decision makers who are looking for new product launches, market penetration, advancement, application demonstrating, utilization of innovations and those who are looking fresh investments post covid -19.

The medical cannabis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 25.16% in the forecast period of 2021 to 2028 is expected to reach USD 67,354.01 million by 2028. Increased medical use and legalization of cannabis is acting as a driver for the medical cannabis market.

The major players who are leading the market throughout the globe are: 

TilrayElixinol Global LimitedMedical Marijuana, IncExtractasPeace Naturals Project IncBOL PharmaPharmaHemp, Kiehl’s (A Subsidiary of L’ORÉAL)Vermont Hemp HealthDiscover Health LLCENDOCAPacific rootsCANOPY GROWTH CORPORATIONAurora CannabisGW Pharmaceuticals plcHarmony, Pure RatiosMARY’s nutritionalsBioactive Solutions, IncUpstate Elevator Supply CoFOLIUM BIOSCIENCESEcoGen BiosciencesAlthea Company Pty Ltd (A Subsidiary of Althea Group Holdings Limited)ApothecannaZenabis Global LtdCresco LabsIDT AustraliaMEDIFARMGreenwich Biosciences, IncMediPharm Labs IncTHC Global Group LimitedSeed CellarCANNABIS SEEDS USASeeds For MeHUMBOLDT SEED COMPANYCrop King SeedsBARNEY’S FARM, and Aphria Inc

Medical Cannabis Market Segmentation:

By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others)

By Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD)

By Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others)

e-mail icon

Cannabis, THC, and marijuana are among the most talked about topics in our society today, and there are probably few people who are not familiar with them. Although THC is socially relevant, most people are likely unaware of its historical background. There are many questions around cannabis, primarily THC. We are here to help. Learn what you need to know to no longer be one of those people who do not know! Check out more  details online from Homegrown Cannabis Co.

 

 

THC – what is it?

As a cannabinoid, THC interacts with the body’s endocannabinoid system when consumed. THC and CBD are two of the most widely used and popular cannabinoids, and both are often misunderstood. Comparing THC and CBD, you can see that both drugs have a lot in common, but they also have their differences. THC is short for tetrahydrocannabinol. This cannabinoid is psychoactive and binds to the CB1 receptor. As opposed to THC, CBD, which stands for cannabidiol, is non-psychoactive, can help regulate various effects of THC, and binds to the CB2 receptor. 

THC binds to CB1 receptors, responsible for regulating bodily functions like appetite, metabolism, and mood. The body reacts to THC by binding to these receptors, and marijuana is known for these side effects: 

Happiness

e-mail icon

Cannabis farmers tend to aim for high THC content cultivars of weed when they’re creating a new strain, without giving much thought to the effect these compounds have on the user’s body.

The potency of cannabis is determined by the content level of CBD and THC compounds present in the plant. So, it is normal to be curious about the exact amount of THC and CBD present in a cannabis product before smoking.

In the last decade, hundreds of new strains of cannabis have been created giving smokers a wide range of options to choose from. No two strains of weed can offer exactly the same characteristics. The taste and aftereffects of each cultivar will be distinct from one another.

This has caused a deviation from the normal cannabis culture practiced in the ’70s and ’80s. Back then there were fewer cannabis cultivars and everyone had an idea of the amount of THC and CBD present in them.

Now, THC and CBD content levels have risen and can be as high as 30% in a weed product, with extracts having very high levels of CBD or THC compounds.

Hemp Industries Association Urges Regulation, Not Prohibition, Of Delta-8 THC

A notification to FDA by Charlotte’s Web to demonstrate the safety of its full-spectrum hemp extract was met with objections in a letter made public Wednesday, underscoring regulatory challenges plaguing the hemp-based CBD market in the U.S.

The development highlights Congress must intervene to clear a pathway for hemp-based CBD products, several industry executives said.

“This is just simply a clarion call for the passage of legislation to provide a legal pathway for the sale of CBD,” said Jonathan Miller, general counsel to the U.S. Hemp Roundtable, in an interview.

GW Pharmaceuticals hurdle 

Charlotte’s Web (and others) cited material differences between its full-spectrum hemp extract and the CBD drug known as Epidiolex, the latter of which FDA approved in 2018. Yet FDA concluded the new dietary ingredient (NDI) from Charlotte’s Web is excluded from the definition of a supplement because CBD was first authorized for investigation as a new drug.

“Looking at the totality of the record, FDA has concluded that your NDI 1202 is a CBD product and thus is subject to the exclusion from the definition of dietary supplement” under U.S. law and “may not be marketed as or in a dietary supplement,” wrote Cara Welch, acting director of FDA’s Office of Dietary Supplement Programs (ODSP).

e-mail icon

The North Carolina Senate is considering Senate Bill 711, The Compassionate Care Act, which would legalize medical marijuana in this state.

The sponsors say this act would give North Carolina the strictest medical marijuana law in the country.

Below are some questions and answers about who could get medical marijuana and how a medical marijuana law would be implemented if S711 becomes law.

This information is current as of  early August 2021 and is subject to change. The latest version of S711 is available at the N.C. General Assembly website.

Rules for patients

How would someone qualify to get medical marijuana?

e-mail icon

When voters approved legalizing recreational marijuana in November 2018, at least $40 million in tax revenue was slated to study marijuana’s effect on PTSD.

By Maureen Meehan

The state of Michigan is funding two major medical cannabis research projects to the tune of $20 million with tax revenue from the state’s recreational marijuana program, announced Michigan’s Marijuana Regulatory Agency (MRA).

And there’s no shortage of cannabis cash in Michigan. Cannabis sales for the month of June alone hit $149 million. Actually, April and May were about the same.

PTSD Research

The money for the Veteran Marijuana Research (VMR) Grant Program is earmarked for clinical trials that will focus on cannabis as a treatment for military vets who are suffering from post-traumatic stress disorder (PTSD).


BY COLLEEN DEGUZMAN AUG. 11, 2021  David Bass came home to Fort Worth in 2006 after serving in the Army but sometimes he feels like he's still in Iraq. After his 25 years in the military, the 64-year-old Desert Storm veteran had nightmares almost every night for six years about being back on th...

Thanks to the passage of the 2018 Farm Bill, CBD containing less than 0.3% of THC (the psychoactive component of marijuana) is everywhere. And hemp seed oil in products has been around for decades. But aren’t CBD oil and hemp seed oil the same thing? Not quite.

While both are derived from the cannabis sativa plant and both are legal at the federal level, they are more like cousins than identical twins. Unfortunately, the terms are sometimes used interchangeably or in misleading ways in advertising. Often, both are misnomered as “hemp oil,” which neither truly is. Let’s clear things up.

Hemp Seed Oil

Hemp seed oil is derived from the seeds themselves and does have some potential health benefits, including an ideal ratio of rich fatty acids. These omegas may help with cardiovascular health by reducing the speed of plaque buildup in the arteries along with lowering blood pressure. Hemp seed oil is also frequently promoted as a beauty ingredient, benefitting skin, hair and nails. Hemp has long been grown for its fiber and industrial uses.

CBD Oil

CBD oil utilizes the stalks, leaves and flowers of the plant and is usually cultivated for its high concentration of CBD (cannabidiol), one of the compounds found in the cannabis sativa plant. Unlike hemp seed oil, CBD directly affects the endocannabinoid system (ECS), a recently discovered system in the body that helps regulate many other systems.

CBD oil, along with other compounds from the plant, is promoted as having the potential to help manage anxiety and depression, reduce stress, promote alertness and focus, improve sleep quality, boost mood, relieve pain, reduce inflammation and reduce the occurrence of epileptic events.

e-mail icon

 Each time Chayse Roth drives home to North Carolina, he notices the highway welcome signs that declare: “Nation’s Most Military Friendly State.”

“That’s a powerful thing to claim,” said Roth, a former Marine Corps gunnery sergeant who served multiple deployments to Iraq, Afghanistan and Pakistan.

Now he says he’s calling on the state to live up to those words. A Wilmington resident, Roth is advocating for lawmakers to pass a bill that would legalize medical marijuana and allow veterans with post-traumatic stress disorder and other debilitating conditions to use it for treatment.

“I’ve lost more men to suicide since we went to Afghanistan in ’01 than I have in combat,” said Roth, who said he doesn’t use cannabis himself but wants others to have the option. “It’s just unacceptable for these guys to go overseas and win the battle and come home and lose the battle to themselves.”

In a state that’s home to eight military bases, one of the largest veteran populations in the country and a Republican-controlled legislature that prides itself on supporting the troops, they hope their voices will act as a crucial lever to push through a bill that has faced opposition in the past.

The North Carolina Senate Finance Committee’s hearing on the medical marijuana bill last month was packed with observers. The bill passed and proceeded to the Senate Health Committee.

Hemp, Inc. (OTC PINK: HEMP), an established leader in the industrial hemp market, is pleased to see top-level athletes embracing CBD as part of their training programs.

Effective Jan. 1, 2018, the World Anti-Doping Agency (WADA) removed CBD from its list of prohibited substances. The change allowed athletes to incorporate CBD into their training regimes for the postponed 2020 Tokyo Olympic Games.

Competitors in the delayed 2020 Summer Games, including softball outfielder Hayley McCleney and hurdler Devon Allen, are among those who utilized CBD products in the runup to the Olympic competition.

Olympic gold medalists Megan Rapinoe and Sue Bird also use hemp-derived CBD for natural wellness solutions. “I use [CBD] right after training,” Rapinoe said. “It’s my go-to to calm me down after a hard training or game, as well as for sleep.”

The Summer Olympics were in Tokyo, Japan, through Aug. 8, 2021. However, Japan’s strict anti-cannabis laws don’t permit athletes to take hemp products across international borders.

“It’s quite frustrating that I can’t use them to compete on the world’s biggest stage,” Rapinoe said.

e-mail icon
 

Doctors treating epilepsy patients say they will shun the Government’s medicinal cannabis access programme over concerns of “inappropriate and potentially harmful” products being made available under it.

Nine neurologists, along with patient organisations, have written to Minister for Health Stephen Donnelly expressing concern over the products likely to be offered.

To date, the four products accepted for inclusion all contain THC, the psychoactive compound in cannabis.

“Not only is there a lack of evidence to support the use of THC in epilepsy, but there are significant concerns regarding its psychiatric and cognitive effects, particularly when used in children,” the letter states.

While CBD, another compound in cannabis, is proving to be relatively safe for patients under clinical supervision, the doctors point out that no products containing pure CBD have been accepted for use under the programme.

Brendan Hogan and his son Ben from Ballon, Co Carlow.

Maine’s adult-use cannabis retailers sold over $9 million worth of marijuana products in July, topping the previous month’s record by 45 percent. 

Retailers attribute the sales jump to an increasingly diverse market and a boost from summer tourists taking advantage of the state’s legal cannabis market. 

The state’s 44 licensed adult-use retailers reported 124,004 sales transactions totaling over $9.4 million last month, earning the state roughly $943,500 in tax revenue, according to data from the Maine Office of Marijuana Policy. 

Recreational cannabis sales in Maine have climbed steadily since the market launched less than a year ago, with retailers bringing in about $1.1 million in the first month and setting new records each month after. 


Replacing your alcohol addiction with a weed addiction is not the way to wean yourself off of alcohol. Here are some potentially helpful insights as to why.

The other day I stumbled on a post on Reddit written by a former booze hound who switched to cannabis to quit drinking.

The post went like this:

I quit drinking about 16 months ago, but I immediately started smoking more pot. Then I started vaping the high-concentrate waxes and shatter, and drinking tonics that are 100mg THC per bottle. I was putting massive amounts of THC in me. So, obviously, I was sober from booze, but not addiction-free because I was doing THC. If you do this- watch out- I quit the THC a few months ago and had major depression for a couple weeks afterwards. People say there is no withdraw from pot- they are trying to sell pot to you, or they just don’t know. There is withdraw, and it is NO fun. I’m sure the severity varies from person to person. So if you do pot, I’d recommend small doses! I have since quit.. once a month maybe I’ll smoke some flower. (Pot is legal in my state) – Reddit

While it’s good that the Redditor in question managed to wean off high doses of weed, and essentially break the cycle of addiction, it’s important to note that while weed can help you quit alcohol, it can also fill the space that the addiction to alcohol created.


Although the German Federal Government legalized medical cannabis only in 2017, its approach to release licenses and the large demand created an attractive market for well-established medical cannabis companies.

The success of the German medical cannabis market has brought Cannovum AG to become the first publicly traded medical cannabis company in Germany. The fully licensed pharmaceutical wholesaler, importer, and manufacturer was listed on the Düsseldorf Stock Exchange in May 2021.

Such achievement represents a significant milestone for the medical cannabis market in Germany. Today, Germany represents the largest and the most profitable medical cannabis market in Europe. 

Market intelligence firm Prohibition Partners has estimated over 128,000 patients receive medical cannabis in Germany annually. Insurance companies reimbursed around 60% of medical cannabis prescriptions in 2019.

Although its medical cannabis policy is very young, Germany is to lead the European cannabis market in terms of growth. Over a million German patients will have access to medical cannabis by 2024, and the German medical market alone will be worth €7.7 billion by 2028.

e-mail icon

We continue to see several conflations and misconceptions voiced in the discussion about microbial safety standards for cannabis products. The foundation for these misconceptions is the idea that cannabis testing regulations should mimic the food industry. We reject this idea because cannabis flower has two major departures from food: it contains high concentrations of antibiotics and it is dried and inhaled.

Cannabis Flower Contains High Concentrations of Antibiotics

As much as 20% of cannabis flower weight/volume is made up of cannabinoids, which are potent antibiotics. We have not seen any food on the market that is 20% (weight/volume) antibiotic.

Furthermore, each cannabis cultivar has a unique combination of cannabinoids and each cannabinoid has its own antimicrobial spectrum. For example. THC has different antibiotic properties than CBD and CBG. So one can assume that each unique flower chemotype creates a unique matrix that will affect the resulting colony counts. An effect not dissimilar to the one we observed when comparing different culture media.

Failure to purify these antibiotics from solution during homogenization will result in chemotype to chemotype variation and require each chemotype to be validated for microbial counts. This is daunting and no one in the cannabis industry is doing this despite it being well known that if the matrix changes you must revalidate. This lack of purification seen in plating methods is a weakness not seen in molecular methods that purify the sample before enumerating DNA molecules.

Additionally, because the cannabis flower’s natural antibiotics are packaged into trichomes, it is only when samples are aggressively homogenized that they are allowed to alter the microbiome on the flower. This effect is not seen by cannabis consumers who simply vaporize a non-homogenized flower sample, which means the test is not representative of what consumers experience.